Abstract:Biodegradable micelles were prepared from poly(3-caprolactone)-g-poly(2-hydroxyethyl methacrylate) (PCL-g-PHEMA) graft copolymers and investigated for controlled release of doxorubicin (DOX). PCL-g-PHEMA copolymers were readily obtained by controlled ring-opening copolymerization of acryloyl cyclic carbonate and 3-caprolactone, Michael-type conjugate addition reaction with cysteamine, coupling reaction with 4-cyanopentanoic acid dithionaphthalenoate (CPADN) via carbodiimide chemistry, and reversible addition–fragmentation chain transfer (RAFT) polymerization of 2-hydroxyethyl methacrylate (HEMA). H NMR analyses showed thatMn of PHEMA ranged from 8.7, 16.3 to 33.8 kg mol , in proximity to the design as well as those determined by gel permeation chromatography (GPC). Differential scanning calorimetry (DSC) revealed that all three PCL-gPHEMA graft copolymers had depressed melting temperatures (Tm 1⁄4 31.3–32.5 C) and low crystallinities (Xc 1⁄4 3.05–5.66%). Dynamic light scattering (DLS) showed that PCL-g-PHEMA formed monodisperse micelles with low polydispersity indexes of 0.04–0.16 and average sizes ranging from 80.5 to 179.7 nm depending on PHEMA chain lengths. These graft copolymers displayed low critical micelle concentrations (CMCs) of 0.051–0.151 mM. The micellar sizes decreased following loading with DOX while PDI remained low. Interestingly, in vitro drug release studies showed that DOX-loaded PCL-g-PHEMA micelles exhibited superior pH-responsive release behaviors, in which up to 94.5% of DOX was released in 3 d at pH 5.0 while DOX release was significantly slower at pH 7.4 (maximum 54.1% release in 3 d). MTT assays with HeLa cells demonstrated that DOX-loaded PCL-g-PHEMA micelles retained high anti-tumor activity with low IC50 (half inhibitory concentration) of 1.47–1.74 mg DOX equiv. mL 1 while PCL-g-PHEMA micelles were practically non-toxic up to a tested concentration of 80 mg mL . These novel biodegradable PCL-g-PHEMA graft copolymer micelles with low CMC, small and tunable sizes, high drug loading, and pH-responsive drug release have emerged as superior nanocarriers for ‘‘smart’’ tumor-targeting drug delivery.

Fabrication of Thermoresponsive, Core‐crosslinked Micelles Based on Poly[n‐isopropyl Acrylamide‐co‐3‐(trimethoxysilyl)propylmethacrylate]‐b‐poly{n‐[3‐(dimethylamino)propyl]methacrylamide} for the Codelivery of Doxorubicin and Nucleic Acid

Fabrication of Core Crosslinked Polymeric Micelles as Nanocarriers for Doxorubicin Delivery: Self-Assembly, In Situ Diselenide Metathesis and Redox-Responsive Drug Release

Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.

Drug and Plasmid Dna Co-Delivery Nanocarriers Based on Abctype Polypeptide Hybrid Miktoarm Star Copolymers

Facile Preparation of Core Cross-Linked Micelles from Catechol-Containing Amphiphilic Triblock Copolymer

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

New Liquid Crystal Polycarbonate Micelles for Intracellular Delivery of Anticancer Drugs

PH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery

Fabrication of Star-Shaped, Thermo-Sensitive Poly(n-Isopropylacrylamide)–cholic Acid–poly(ɛ-Caprolactone) Copolymers and Their Self-Assembled Micelles As Drug Carriers

Polymeric Micelles with Π–π Conjugated Cinnamic Acid As Lipophilic Moieties for Doxorubicin Delivery

A Ph-Sensitive Micelle for Codelivery of Sirna and Doxorubicin to Hepatoma Cells

Interface Crosslinked Mpeg-B-page-b-pcl Triblock Copolymer Micelles with High Stability for Anticancer Drug Delivery.

Biamphiphilic Triblock Copolymer Micelles As A Multifunctional Platform for Anticancer Drug Delivery

C2JM30700F 11730..11738

Core-crosslinked amphiphilic biodegradable copolymer based on the complementary multiple hydrogen bonds of nucleobases: Synthesis, self-assembly and in vitro drug delivery

Using Poly(N‐isopropylacrylamide) and Poly(ethyleneglycol) Grafted Polycarbodiimides as Unique Nanocarriers for Hydrophobic Form of the Doxorubicin (DOX)

Sheddable, Degradable, Cationic Micelles Enabling Drug and Gene Delivery

Tumor Targeting by Ph-Sensitive, Biodegradable, Cross-Linked N-(2-hydroxypropyl) Methacrylamide Copolymer Micelles.

Core Cross-Linked Polyphosphoester Micelles with Folate-Targeted and Acid-Cleavable Features for Ph-Triggered Drug Delivery

Micellar Carriers Based on Block Copolymers of Poly(ε-Caprolactone) and Poly(ethylene Glycol) for Doxorubicin Delivery

Reduction/temperature/pH Multi-Stimuli Responsive Core Cross-Linked Polypeptide Hybrid Micelles for Triggered and Intracellular Drug Release.